Abstract
Multiple Myeloma (MM) is characterized by the uncontrolled proliferation of malignant monoclonal plasma cells in the bone marrow, affecting the production of blood cells. New treatment strategies use Natural Killer (NK) cells, mainly due to their ease of manipulation in vitro, generating NK cells with an enhanced profile for tumor control. In the presence of the cytokine combination of IL…